研究报告 |
|
|
|
|
基于T7启动子表达系统的呼吸道合胞病毒微型基因组的拯救 |
袁锐1,2, 付远辉2, 何金生2, 焦月盈2, 蒋桂云1,2, 张梅1, 彭向雷2, 阚学通1,2 |
1. 安徽医科大学免疫学教研室 合肥 230032; 2. 北京交通大学生命科学与生物工程研究院 北京 100044 |
|
Rescue of the Minigenome of Human Respiratory Syncytial Virus Based on T7 Promoter Expression System |
YUAN Rui1,2, FU Yuan-hui2, HE Jin-sheng2, JIAO Yue-ying2, JIANG Gui-yun1,2, ZHANG Mei1, PENG Xiang-lei2, KAN Xue-tong 1,2 |
1. Department of Immunology, Anhui Medical University, Hefei 230032, China; 2. College of Life Sciences and Bioengineering, Beijing Jiaotong University, Beijing 100044, China |
引用本文:
袁锐, 付远辉, 何金生, 焦月盈, 蒋桂云, 张梅, 彭向雷, 阚学通. 基于T7启动子表达系统的呼吸道合胞病毒微型基因组的拯救[J]. 中国生物工程杂志, 2013, 33(9): 1-9.
YUAN Rui, FU Yuan-hui, HE Jin-sheng, JIAO Yue-ying, JIANG Gui-yun, ZHANG Mei, PENG Xiang-lei, KAN Xue-tong. Rescue of the Minigenome of Human Respiratory Syncytial Virus Based on T7 Promoter Expression System. China Biotechnology, 2013, 33(9): 1-9.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/
或
https://manu60.magtech.com.cn/biotech/CN/Y2013/V33/I9/1
|
[1] Yoshihiko M. Respiratory syncytial virus vaccine development. Clin Lab Med, 2009, 29(4): 725-739. [2] Beeler J A, Eichelberger M C. Influenza and respiratory syncytial virus (RSV) vaccines for infants: safety, immunogenicity, and efficacy. Microb Pathogenesis, 2013, 55: 9-15. [3] Chang J. Current progress on development of respiratory syncytial virus. BMB Rep, 2011, 44(4): 232-237. [4] Collins P L, Melero J A. Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years. Virus Res, 2011, 162(1-2): 80-99. [5] Collins P L, Crowe J E Jr.Respiratory syncytial virus and metapneumovirus. In: Knipe D M, Howley P M, Griffin D E, et a1. Fields Virology. 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2007. 1601-1646. [6] 何金生,付远辉,洪涛. 人呼吸道合胞病毒活疫苗研究进展. 中国科学,2011,41(1): 1-12. He J SH, Fu Y H, Hong T. Live vivus vaccines against human respiratory syncytial virus. Scientia Sinica Vitae, 2011, 41(1): 1-12. [7] 虞结梅,何金生,李栋梁,等. 人呼吸道合胞病毒RNA聚合酶复合体蛋白N、P的克隆和表达鉴定. 中国病毒学, 2006, 21(3): 213-216. Yu J M,He J SH,Li D L,et al. Expression and identification of Nucleoprotein and phosphoprotein of RNA ploymerase complex of human respiratory syncytial virus. Virologica Sinica, 2006, 21(3): 213-216. [8] 虞结梅,杨兵,谢灿,等. T7 RNA聚合酶的克隆及其介导基因转录功能的鉴定. 安徽医科大学学报, 2007, 42(3): 272-275. Yu J M,Yan B,Xie C,et al. Clone and function of transcriptase identified of T7 RNA ploymerase.Acta Universitatis Medicinalis Anhui, 2007, 42(3): 272-275. [9] 唐倩,虞结梅,何金生,等. 人呼吸道合胞病毒微型复制子的构建. 微生物学报, 2009, 49(8): 1048-1054. Tang Q, Yu J M, He J SH, et al. Construction of minireplicon of human respiratory syncytial virus. Acta Microbiologica Sinica, 2009, 49(8): 1048-1054. [10] Fearns R, Collins P L. Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription. J Virol, 1999, 73(7): 5852-5864. [11] Collins P L, Whitehead S S, Bukreyev A, et al. Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics. Adv. Virus Res, 1999, 54, 324-351. [12] Bermingham A, Collins P L. The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription. Proc Natl Acad Sci U S A,1999, 96(20): 11259-11264. [13] Pattnaik A K, Ball L A, LeGrone A W, et al. Infectious defective interfering particles of VSV from transcripts of a cDNA clone. Cell, 1992, 69(6): 1011-1020. [14] Ghanem A, Kern A, Conzelmann K K. Significantly improved rescue of rabies virus from cDNA plasmids. Eur J Cell Biol,2012,91(1):10-16. [15] Buchholz U J, Finke S, Conzelmann K K. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol, 1999, 73(1): 251-259. [16] Grosfeld H, Hill M G, Collins P L. RNA replication by respiratory syncytial virus (RSV) is directed by the N, P, and L proteins; transcription also occurs under these conditions but requires RSV superinfection for efficient synthesis of full-length mRNA. J Virol, 1995, 69(9): 5677-5686. [17] Collins P L, Hill M G, Camargo E, et al. Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA and provides a capability for vaccine development. Proc Natl Acad Sci USA, 1995, 92(25): 11563-11567. [18] Samal S K, Collins P L. RNA Replication by a respiratory syncytial virus RNA analog does not obey the rule of six and retains a nonviral trinucleotide extension at the leader end. J Virol, 1996, 70(8): 5075-5082. [19] Bradrick S S, Dobrikova E Y, Kaiser C, et al. Poly(A)-binding protein is differentially required for translation mediated by viral internal ribosome entry sites. RNA, 2007, 13(9): 1582-1593. [20] Kieft J S. Viral IRES RNA structures and ribosome. Trends Biochem Sci, 2008, 33(6): 274-283. [21] Kaur J, Tang R S, Spaete R R, et al. Optimization of plasmid-only rescue of highly attenuated and temperature-sensitive respiratory syncytial virus (RSV) vaccine candidates for human trials. J Virol Methods, 2008, 153(2): 196-202. [22] Witko S E, Kotash C S, Nowak R M, et al. An efficient helper-virus-free method for rescue of recombinant paramyxoviruses and rhadoviruses from a cell line suitable for vaccine development. J Virol Methods, 2006, 135(1): 91-101. [23] Parks C L, Lerch R A, Walpita P,et al.Enhanced measles virus cDNA rescue and gene expression after heat shock. J Virol, 1999, 73(5): 3560-3566. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|